Accession Number: | 0001140361-21-021491 |
Date: | 2021-06-15 |
Issuer: | PDS BIOTECHNOLOGY CORP (PDSB) |
Original Submission Date: |
VAN VOORHEES SETH
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK, NJ 07932
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-15 | P | 17,647 | a | $8.50 | 17,647 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents shares of common stock purchased by the reporting person at the public offering price in connection with the issuer's firm commitment underwritten public offering of common stock, which closed on june 17, 2021, and such shares of common stock are subject to a lock up agreement between the reporting person and cantor fitzgerald & co., pursuant to which the shares cannot be sold for 90 days following june 15, 2021. |